Jason Gill,Paul Loadman,Rob Falconer,Laurence Patterson,Jennifer Xavier,Michael Bibby
申请号：
US15923564
公开号：
US20180228910A1
申请日:
2018.03.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to compounds, and pharmaceutically acceptable salts thereof, comprising a vascular disrupting agent (VDA) associated and a MMP proteolytic cleavage site. The compounds are useful in the treatment of cancer.
